Eslicarbazepine Acetate Tablet
NDC Package 31722-430-90

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Eslicarbazepine Acetate tablets is eslicarbazepine is used alone or with other medications to treat a certain type of seizure disorder (focal seizures). This formulation utilizes a tablet delivery system. Marketed by Camber Pharmaceuticals, Inc., this product is identified by NDC 31722-430 and is authorized under FDA application ANDA211186.

Identification & Billing

NDC Package Code
31722-430-90
Package Description
90 TABLET in 1 BOTTLE
Product Code
31722-430
11-Digit Billing Format
31722043090
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Eslicarbazepine Acetate
Non-Proprietary Name
Eslicarbazepine Acetate
Substance Name
Eslicarbazepine Acetate
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
ESLICARBAZEPINE ACETATE 600 mg/1
Pharmacologic Class
Usage Information
Eslicarbazepine is used alone or with other medications to treat a certain type of seizure disorder (focal seizures). It belongs to a class of drugs known as anticonvulsants. Eslicarbazepine may reduce the number of seizures you have.

Regulatory & Marketing

Labeler Name
Camber Pharmaceuticals, Inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA211186
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
08-03-2023
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (31722-430). Click a package code to view its specific billing and regulatory data.

31722-430-32
10 BLISTER PACK in 1 CARTON / 10 TABLET in 1 BLISTER PACK (31722-430-31)
31722-430-60
60 TABLET in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 31722-430-90 identifies a specific commercial package of 90 tablet in 1 bottle of Eslicarbazepine Acetate, a human prescription drug labeled by Camber Pharmaceuticals, Inc.. This tablet is formulated for oral use and contains eslicarbazepine acetate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Camber Pharmaceuticals, Inc. on August 03, 2023. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Eslicarbazepine is used alone or with other medications to treat a certain type of seizure disorder (focal seizures). It belongs to a class of drugs known as anticonvulsants. Eslicarbazepine may reduce the number of seizures you have.

How is this Camber Pharmaceuticals, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 31722043090. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
31722-430-90
11-Digit CMS (5-4-2)
31722-0430-90

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.